RPG Life Sciences

1 insight

Brewed Up Insights

RPG Life Sciences buys an approved plant before US tariffs

RPG Life Sciences agreed to pay about 7x sales for an approved API plant, because in pharma the approval takes years and the US tariff clock is already running.

Read more →

3 charts

US generic drug tariffs: 0% now, 100% from August 2028, 200% from August 2029.US generic drug tariffs: 0% now, 100% in 2028, 200% in 2029RPG Life Sciences pays up to ₹135 crore, 7x sales, for Raghava's approved API plant, which did ₹19 crore in FY26.RPG pays up to ₹135 crore, 7x sales, for an approved API plantOutside money pays for both of RPG's plant purchases: ₹243 crore raised, ₹80 crore for Actis and up to ₹135 crore for Raghava.Outside money pays for both of RPG’s plant purchases

Every company we have written about →

Get in touch